The earnings call presented several highlights, including the successful launch of the HEMAcollect PROTEIN product and a strong cash position. However, these were offset by significant challenges, such as disruptions in international diagnostics and a decline in Sample Management revenue. The uncertainty in U.S. Diagnostics further balanced the positive developments.

Company Guidance

In the OraSure Technologies Second Quarter 2025 Earnings Conference Call, the company reported total revenue of $31.2 million, with core revenue at $30.8 million, surpassing the midpoint of their guidance. The diagnostics segment grew by 3% year-over-year, while Sample Management revenue decreased by 22% due to a decline in orders from a major consumer genetics customer. Excluding this impact, Sample Management revenue would have shown positive growth. The international diagnostics business experienced year-over-year growth despite disruptions caused by USAID funding freezes, impacting the pace of HIV test deployments. The U.S. diagnostics revenue remained steady, declining just 1% year-over-year, influenced by potential public health program budget cuts. The company also highlighted the successful transition of manufacturing operations to Pennsylvania, completed ahead of schedule, and the launch of the HEMAcollect PROTEIN offering to support proteomic research. Looking ahead, OraSure guides for third-quarter revenue between $27 million and $30 million, with expectations of a slower pace of international orders and reduced revenue from the Together Take Me Home program.

Successful Launch of HEMAcollect PROTEIN

In July, OTI launched HEMAcollect PROTEIN, which expands their Sample Management Solutions into a new sample type, blood. This product advances proteomic research by offering extended protein stabilization at room temperature and simplified workflows.

Strong Financial Position

OTI ended Q2 with $235 million in cash and cash equivalents and no debt, allowing them to continue investments in innovative products like Sherlock and Colli-Pee.

Renewal Agreement with GeneDx

OTI renewed their agreement with GeneDx, a long-standing customer, to support early diagnosis of rare pediatric diseases using their ORAcollect kits.

Orasure Technologies (OSUR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OSUR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	-0.19 / -	-0.06	―	―	―
Aug 05, 2025	2025 (Q2)	-0.20 / -0.26	-0.01	-2500.00% (-0.25)	―
May 07, 2025	2025 (Q1)	-0.16 / -0.21	-0.05	-320.00% (-0.16)	―
Feb 25, 2025	2024 (Q4)	-0.06 / -0.14	0.27	-151.85% (-0.41)	―
Nov 06, 2024	2024 (Q3)	-0.08 / -0.06	0.15	-140.00% (-0.21)	―
Aug 06, 2024	2024 (Q2)	>-0.01 / -0.01	-0.07	85.71% (+0.06)	―
May 08, 2024	2024 (Q1)	- / -0.05	0.37	-113.51% (-0.42)	―
Feb 27, 2024	2023 (Q4)	0.09 / 0.27	0.21	28.57% (+0.06)	―
Nov 07, 2023	2023 (Q3)	0.05 / 0.15	0.07	114.29% (+0.08)	―
Aug 03, 2023	2023 (Q2)	-0.07 / -0.07	-0.26	73.08% (+0.19)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OSUR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$3.12	$2.86	-8.33%
May 07, 2025	$2.79	$2.60	-6.81%
Feb 25, 2025	$4.00	$3.06	-23.50%
Nov 06, 2024	$4.40	$4.24	-3.64%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Orasure Technologies (OSUR) report earnings?

Orasure Technologies (OSUR) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Orasure Technologies (OSUR) earnings time?

Orasure Technologies (OSUR) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OSUR EPS forecast?

OSUR EPS forecast for the fiscal quarter 2025 (Q3) is -0.19.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing